视网膜静脉阻塞所致黄斑水肿的治疗进展  

Treatment advances of macular edema caused by retinal vein occlusion

作　　者：韩中舒 余锦强 HAN Zhongshu;YU Jinqiang(Training Base of Hubei University of Medicine of Jinzhou Medical University,Shiyan,Hubei,442000)

机构地区：[1]锦州医科大学湖北医药学院培养基地,湖北十堰442000

出　　处：《实用临床医药杂志》2020年第16期122-128,共7页Journal of Clinical Medicine in Practice

摘　　要：视网膜静脉阻塞(RVO)是临床常见的致盲性眼病之一,多为单眼发病,患者视力常呈无痛性下降。黄斑水肿(ME)是RVO最常见的并发症,也是导致RVO患者视力下降的最常见原因,因此积极治疗ME是提高RVO患者视力的关键。RVO的治疗方式有激光治疗、药物治疗、手术治疗等,已成为眼科学中的研究热点,但由于缺乏大规模前瞻性临床试验数据,多种治疗方式的临床疗效及安全性仍在探讨中。现将RVO所致ME的治疗进展综述如下,旨在帮助不同患者寻找到最佳治疗方式。Retinal vein occlusion(RVO)is the one of common retinal vascular diseases,monocular lesion frequently occurring in these patients,and their visual acuity often declines painlessly.The most common complication of RVO is macular edema(ME),which is the most common reason for RVO vision loss,so active treatment for ME is the key to increase the vision of RVO patients.The treatments for RVO,such as laser,drugs,and surgery,etc.,have become hotpots in researches,but their clinical curative effect and safety are still unknown due to lack of large-scale prospective clinical trial data.This article reviewed the recent advances in the treatment of RVO so as to blaze new trails for better treatments.

关 键 词：视网膜静脉阻塞 黄斑水肿 视网膜血管疾病 发病机制 血管内皮生长因子 

分 类 号：R774.1[医药卫生—眼科]